by Market Overview:
Southern blotting is a technique used to detect a specific DNA sequence in fragmented DNA samples derived from cells or tissues. It relies on the specific annealing of a DNA probe to its complementary target DNA on a membrane containing separated DNA fragments from a restriction digest or PCR. Southern blotting plays an important role in research areas such as genomics, epigenomics and disease mapping. It helps researchers identify mutations, deletions, insertions, rearrangements and other modifications to DNA. The use of non-radioactive probes has made southern blotting safer, less expensive and compatible with colorimetric and chemiluminescent detection systems. Southern blotting kits offer standardized reagents and protocols for enhanced reproducibility and reliable results.
Market key trends:
One of the key trends gaining traction in the southern blotting market is the shift towards digital southern blot analysis. Traditionally, southern blot results were visualized by X-ray films or fluorescence detection, which lacked quantification capabilities. However, newer digital platforms help automate southern blot workflows and provide quantitative results through digital image capture and analysis. This enables high-throughput analysis and extraction of more insightful data. It also avoids the risks and environmental hazards associated with radioisotope use in conventional southern blotting. Marker software integrated with digital imaging systems help size DNA fragments accurately. This transition to digitalization is expected to boost adoption rates of southern blotting techniques in life sciences research over the forecast period.
The global Southern Blotting Market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Porter’s Analysis
Threat of new entrants: Low capital requirements and economies of scale enjoyed by the established players make the threat from new entrants low in the Southern Blotting market.
Bargaining power of buyers: The buyers have high bargaining power due to availability of substitutes. However, stringent regulations favor the established brands.
Bargaining power of suppliers: Established players have high bargaining power over suppliers due to their dominance and economies of scale of operations.
Threat of new substitutes: Technological advances have increased the availability of substitutes like PCR and DNA sequencing. This increases threat from substitutes.
Competitive rivalry: The Southern Blotting market is consolidated with few global players dominating the market. Intense competition exists between the players.
Key Takeaways
The global Southern Blotting Market Growth is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period, due to increasing R&D investments in life sciences.
Regional analysis: North America is expected to dominate the global Southern Blotting market during the forecast period. This is attributed to presence of major players, availability of funding for research and product development. Asia Pacific region is expected to exhibit fastest growth in the market during the forecast period.
Key players: Key players operating in the Southern Blotting market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Agilent Technologies, PerkinElmer, GE Healthcare, Promega Corporation, Genetec, Bio-Rad Laboratories, Abcam. Key players are focusing on new product launches and expansions to strengthen their geographical presence
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
